Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 17, 16:00
1173.05
3.05 (0.26%)
VOLUME 1,348
LIVE
NSE
Nov 17, 15:53
1177.15
5.2 (0.44%)
VOLUME 4,738
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Sep '17 Jun '17 Mar '17 Dec '16 Sep '16
Net Sales/Income from operations 164.26 127.48 110.95 141.12 136.14
Other Operating Income -- -- 0.63 9.16 2.02
Total Income From Operations 164.26 127.48 111.58 150.29 138.17
EXPENDITURE
Consumption of Raw Materials 3.12 5.48 5.30 2.44 3.06
Purchase of Traded Goods 47.78 58.44 28.08 35.67 27.62
Increase/Decrease in Stocks 2.55 -18.77 4.32 8.93 13.49
Power & Fuel -- -- -- -- --
Employees Cost 36.40 34.94 36.07 38.12 46.96
Depreciation 3.75 3.71 3.68 4.02 4.06
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 15.26 11.86 -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 23.49 29.32 42.55 50.18 43.82
P/L Before Other Inc. , Int., Excpt. Items & Tax 31.90 2.51 -8.42 10.92 -0.84
Other Income 2.50 4.65 6.43 9.83 1.82
P/L Before Int., Excpt. Items & Tax 34.40 7.16 -1.99 20.75 0.98
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax 34.40 7.16 -1.99 20.75 0.98
Exceptional Items -- -- -- -- --
P/L Before Tax 34.40 7.16 -1.99 20.75 0.98
Tax 7.01 1.37 0.88 4.79 0.19
P/L After Tax from Ordinary Activities 27.38 5.80 -2.88 15.96 0.79
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 27.38 5.80 -2.88 15.96 0.79
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 10.95 2.32 -1.15 6.39 0.31
Diluted EPS 10.95 2.32 -1.15 6.39 0.31
EPS After Extra Ordinary
Basic EPS 10.95 2.32 -1.15 6.39 0.31
Diluted EPS 10.95 2.32 -1.15 6.39 0.31
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.